Boston Scientific Corp

NYSE: BSX
$88.97
-$1.03 (-1.1%)
Real Time Data Delayed 15 Min.

BSX Articles

With top biotechnology and health care companies from around the world attending the Leerink Global Healthcare, it is a good chance for investors to get timely updates on the top stocks and their...
These are the top analyst upgrades, initiations and positive analyst research calls seen from Wall Street on Monday, January 6.
ThinkstockInvestors have enjoyed a handy recovery in the turnaround of Boston Scientific Corp. (NYSE: BSX). Perhaps that should even say “finally enjoyed” in the turnaround. After all, this stock...
ThinkstockHealth care has been a top sector for investors this year. The research team at Oppenheimer continues to believe that health care remains well positioned to deliver further market-topping...
ThinkstockThe unemployment situation in the United States looked relatively good through the first half of the year. The jobless rate dropped to 7.3% in October from 7.9%% at the beginning of the...
The first half of 2013 signaled that many significant business turnarounds actually were taking hold. After going back over our list of nine promising turnaround stocks from April, it turns out...
ThinkstockIn 2012, the S&P 500 Healthcare Equipment & Supply index was up 15.1%, while the S&P 500 was up 13.4%. However, it was in-line with the broader S&P 500 Healthcare index,...
ThinkstockA new communication has been issued by the U.S. Food & Drug Administration (FDA) for medical device manufacturers. This may sound like it is out of a science fiction movie, but the...
Investors and traders are usually on the lookout for new research ideas that will generate higher income or more profits. 24/7 Wall St. reviews many analyst research calls from Wall Street and from...
Investors and traders frequently search for fresh research ideas that will lead to higher income or more profits. 24/7 Wall St. reviews many fresh research calls to find great ideas to find value...
These are the top analyst upgrades, downgrades and initiations from select Wall Street research calls on Friday, April 26, 2013. They include Amazon, Boeing, eBay, SunPower and Anheuser-Busch InBev.
Boston Scientific Corp. (NYSE: BSX) may have been the premier medical supply company in the world — in 2006, before it bought rival Guidant, then had a series of problems with its stents and other...
Thinkstock24/7 Wall St. recently featured the waves of the most promising turnarounds for 2013. It was amazing to see some of the battered yet recovered stocks on that list. Some of the turnarounds...
Jon OggSo far, 2013 has been a great year for equity investors. With both the Dow Jones Industrial Average and the S&P 500 Index trading up in the double-digits, we wanted to take a look at those...
Jon OggBoston Scientific Corp. (NYSE: BSX) is in a long-term turnaround that frankly just feels like it never really has turned around. Or has it? We can criticize the mistakes of management from...